Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Graham Holdings Company Common Stock (GHC) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Graham Holdings Company Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Graham Holdings Company Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,186.01 (market cap $4.97B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 2.2× Graham Holdings Company Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays the higher dividend (0.65%). Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

GHCRDY
Market Cap
$4.97B$10.78B
Volume
27,3832,724,343
Sector
IndustrialsHealth
52-Week High
$1.23K$15.38
52-Week Low
$949.84$11.38
Typical Hold Time
0 Days0 Days
Enterprise Value
$5.06B$10.68B
Dividend Yield
0.64%0.65%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GHC
100% Buy0% Sell
Avg holding period · 0 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About Graham Holdings Company Common Stock

Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.

Read more on GHC →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →